To me, before you can really understand how the scam works you need to understand Brian Conway founded Waypoint, he owns the IR firm OZSC is signed upto ( and pays 10k a month )
Why does a company with no revenues need an IR firm anyway ?
Also, look at how the Toxic Note scam as performed...
Is this simply taking out toxic debt at the expense of share holders and then filtering the cash out of the firm to himself ( via outlets like Waypoint ), or is he part of the toxic note holders themselves. Is he also been paid directly by converting the shares.
If you look at the Fins various unnamed consultants have been paid for unspecified work.. Are these family ?
Take a look at the below... remember nothing was happening in the company ZERO Revenue and only 60k product development.
Stock based compensation for the six months ended June 30, 2020 is comprised of:
? On March 24, 2019, the Company signed a one-year consulting agreement with a consultant. As compensation for its services under the agreement, the consultant and its assignees received 171 shares of the Company’s common stock. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the six months ended June 30, 2020, the Company amortized $17,783 as stock-based compensation expense.
? On September 3, 2019, the Company signed a six- month consulting agreement with a consultant. As compensation for its services under the agreement, the consultant received 1,250 shares of the Company’s common stock. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense.
? On September 3, 2019, the Company signed a six- month consulting agreement with a consultant. As compensation for its services under the agreement, the consultant received 1,250 shares of the Company’s common stock. The Company valued the shares at $46,875, based on the market price of the common stock on the date of the agreement, to be amortized over the term of the contract. For the six months ended June 30, 2020, the Company amortized $15,625 as stock-based compensation expense.
Stock based compensation for the three and six months ended June 30, 2019 is comprised of:
? Amortization of $162,500 related to a one-year consulting agreement effective on August 31, 2018, pursuant to the issuance of 650 shares of common stock. The Company valued the shares at $500 per share (the price the Company was selling shares of common stock on the date of the agreement). The Company recorded $325,000 as deferred stock compensation to be amortized over the term of the agreement, and accordingly has included $81,250 and $162,500 in stock-based compensation for the three and six months ended June 30, 2019, respectively.
? On October 19, 2018, the company recorded the issuance of 450 shares of common stock, as the first tranche of a one- year consulting agreement requiring a total of 1,800 shares. The Company valued the shares issued at $500 per share (the price the Company was selling shares of common stock on the date of the agreement). The Company recorded $225,000 as deferred stock compensation to be amortized over the first three months of the agreement, and accordingly has included $52,500 in stock-based compensation for the six months ended June 30, 2019.
? For the six months ended June 30, 2019, the Company recorded 900 shares of common stock to be issued pursuant to the one-year agreement above to issue 1,800 shares. The 900 shares were valued at $400,470, based on the market price of the common stock on their respective date of issuances, and the Company expensed $135,450 and $395,290 as stock-based compensation for the three and six months ended June 30, 2019, respectively.
? On March 24, 2019, the Company signed a one-year consulting agreement with Newbridge. As compensation for its services under the Agreement, Newbridge and its assignees received 172 shares of the Company’s common stock. The Company valued the shares at $77,130, based on the market price of the common stock on the date of the agreement, to be amortized over the one-year term of the contract. For the three and six months ended June 30, 2019, the Company amortized $19,282 and $20,782 as stock-based compensation expense, respectively.
? On April 1, 2019, the Company issued 1,000,000 shares of Series B Preferred Stock to the Company’s CEO. The shares were valued at $68,000 of which $25,000 was applied to accrued liabilities-related and $43,000 was recorded as stock-based compensation expense for the three and six months ended June 30, 2019.
? On April 29, 2019, the Company issued 100 shares of common stock for consulting services. The shares were valued at $275 per share (the market price on the date of the agreement) and $27,500 was recorded as stock-based compensation expense for the six and months ended June 30, 2019.
? On May 20, 2019, the Company issued 100 shares of common stock for consulting services. The shares were valued at $120 per share (the market price on the date of the agreement) and $4,500 was recorded as stock-based compensation expense for the three and six months ended June 30, 2019.
